CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccine Strategy
1 March 2022
No Comments
CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products & Packaging services, is pleased to kick-off a major investment project
